Alert detail
LCD L39923: MolDX: Non-Next Generation Sequencing Tests for the Diagnosis of BCR-ABL Negative Myeloproliferative Neoplasms — Noridian
What changed
Changes in billing for myeloproliferative neoplasms testing ahead.
Who’s affected: Hematology billing teams · Effective: February 5, 2026
Primary source: View the official CMS/MAC document ↗
Get the action steps and full analysis
This change affects 15 billing codes.
The full analysis, the revision comparison and the as-of-date version of this policy are what a partner packet carries. The source document above is free and always will be.